Home › Companies › Bio-Rad Laboratories, Inc. › 2025-2026

Bio-Rad Laboratories, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Bio-Rad Laboratories, Inc.’s Form 8-K, filed April 24, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 13Reported items
  • 451Asset managers
  • 2,954Fund votes
  • April 21, 2026Meeting date

Results at a glance

Meeting of April 21, 2026: 6 items on Bio-Rad Laboratories, Inc.’s Form 8-K, filed April 24, 2026: 6 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Bio-Rad Laboratories, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Bio-Rad Laboratories, Inc.

These tallies are Bio-Rad Laboratories, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 24, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Bio-Rad Laboratories, Inc. — official shareholder meeting results, meeting held April 21, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Melinda Litherland 17,316,5232,297,02928,202 --1,351,946 88%Not verified—
Elect Director: Arnold A. Pinkston 17,423,4682,192,57425,712 --1,351,946 89%Not verified—
Elect Director: Jeffrey L. Edwards 4,991,11934693 --31,874 99.9%Not verified—
Elect Director: Gregory K. Hinckley 4,991,07539093 --31,874 99.9%Not verified—
Elect Director: Allison Schwartz 4,991,15231393 --31,874 99.9%Not verified—
Elect Director: Norman Schwartz 4,990,99547093 --31,874 99.9%Not verified—

Source: Bio-Rad Laboratories, Inc., Form 8-K, filed with the SEC on April 24, 2026 — read the filing on EDGAR.

How asset managers voted at the Bio-Rad Laboratories, Inc. 2025-2026 meeting

Each item below shows how the 451 asset managers that disclosed a Bio-Rad Laboratories, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Bio-Rad Laboratories, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Arnold A. Pinkston

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 17,423,468AGAINST: 2,192,574
Details: description as filed, official tally, votes by 116 asset managers

Description as filed by funds: Nominees: Arnold A. Pinkston

Bio-Rad Laboratories, Inc.’s own tally for this item (“Elect Director: Arnold A. Pinkston”): 17,423,468 for, 2,192,574 against, per its Form 8-K filed April 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 116 asset managers below reported 7,704,628 for, 828,809 against, 2,872 abstained, 14 not voted.

FOR
FOR: 7,704,628AGAINST: 828,809ABSTAIN: 2,872NOT VOTED: 14
Largest asset managers voting on “Nominees: Arnold A. Pinkston” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST EAGLE FUNDS1,957,1810 00For
Vanguard1,644,196806 00For
Capital Group764,0420 00For
BlackRock748,9110 00For
ARIEL INVESTMENT TRUST388,1910 00For
Dimensional347,6670 00For
Fidelity35,004274,678 00Mixed
MFS288,7100 00For
Investment Managers Series Trust III259,1060 00For
Parnassus0253,239 00Against
LONGLEAF PARTNERS FUNDS TRUST185,8680 00For
Charles Schwab182,78031 00For
John Hancock133,4081,737 00For
Allspring94,4700 00For
PIMCO88,1860 00For
T. Rowe Price080,749 00Against
Putnam080,552 00Against
Transamerica65,6920 00For
TRUST FOR PROFESSIONAL MANAGERS64,9770 00For
Equitable26,49020,614 00Mixed
RBB Fund Trust46,7620 00For
BOSTON TRUST WALDEN FUNDS038,293 00Against
Jackson National36,6550 00For
FRANKLIN VALUE INVESTORS TRUST034,773 00Against
TIAA26,3270 00For

Showing the 25 largest of 116 asset managers. See all 116 in the interactive database.

2. Elect Director: Melinda Litherland

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 17,316,523AGAINST: 2,297,029
Details: description as filed, official tally, votes by 116 asset managers

Description as filed by funds: Nominees: Melinda Litherland

Bio-Rad Laboratories, Inc.’s own tally for this item (“Elect Director: Melinda Litherland”): 17,316,523 for, 2,297,029 against, per its Form 8-K filed April 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 116 asset managers below reported 7,704,280 for, 829,157 against, 2,872 abstained, 14 not voted.

FOR
FOR: 7,704,280AGAINST: 829,157ABSTAIN: 2,872NOT VOTED: 14
Largest asset managers voting on “Nominees: Melinda Litherland” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST EAGLE FUNDS1,957,1810 00For
Vanguard1,644,196806 00For
Capital Group764,0420 00For
BlackRock748,9110 00For
ARIEL INVESTMENT TRUST388,1910 00For
Dimensional347,6670 00For
Fidelity35,004274,678 00Mixed
MFS288,7100 00For
Investment Managers Series Trust III259,1060 00For
Parnassus0253,239 00Against
LONGLEAF PARTNERS FUNDS TRUST185,8680 00For
Charles Schwab182,78031 00For
John Hancock133,4081,737 00For
Allspring94,4700 00For
PIMCO88,1860 00For
T. Rowe Price080,749 00Against
Putnam080,552 00Against
Transamerica65,6920 00For
TRUST FOR PROFESSIONAL MANAGERS64,9770 00For
Equitable26,49020,614 00Mixed
RBB Fund Trust46,7620 00For
BOSTON TRUST WALDEN FUNDS038,293 00Against
Jackson National36,6550 00For
FRANKLIN VALUE INVESTORS TRUST034,773 00Against
TIAA26,3270 00For

Showing the 25 largest of 116 asset managers. See all 116 in the interactive database.

3. Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan.

No official matchCOMPENSATION

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 119 asset managers

The 119 asset managers below reported 8,523,552 for, 609 against, 10,532 abstained, 14 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,523,552AGAINST: 609ABSTAIN: 10,532NOT VOTED: 14
Largest asset managers voting on “Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan.” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST EAGLE FUNDS1,957,1810 00For
Vanguard1,645,0011 00For
Capital Group764,0420 00For
BlackRock748,9110 00For
ARIEL INVESTMENT TRUST388,1910 00For
Dimensional347,6670 00For
Fidelity309,6820 00For
MFS288,7100 00For
Investment Managers Series Trust III259,1060 00For
Parnassus253,2390 00For
LONGLEAF PARTNERS FUNDS TRUST185,8680 00For
Charles Schwab182,8110 00For
John Hancock135,1450 00For
Allspring94,4700 00For
PIMCO88,1860 00For
T. Rowe Price80,7490 00For
Putnam80,5520 00For
Transamerica65,6920 00For
TRUST FOR PROFESSIONAL MANAGERS64,9770 00For
Equitable47,1040 00For
RBB Fund Trust46,7620 00For
BOSTON TRUST WALDEN FUNDS38,2930 00For
Jackson National36,6550 00For
FRANKLIN VALUE INVESTORS TRUST34,7730 00For
TIAA26,3270 00For

Showing the 25 largest of 119 asset managers. See all 119 in the interactive database.

4. Amend Omnibus Stock Plan

No official matchSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 16,362 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,362
Largest asset managers voting on “Amend Omnibus Stock Plan” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower8,4730 00For
GreenFi Funds Trust7,4890 00For
NORTHERN LIGHTS FUND TRUST II4000 00For
Dixon Mitchell Investment Counsel Inc.00 00--

5. Advisory vote to approve executive compensation.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

85% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 436 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 113 asset managers voting on “Advisory vote to approve executive compensation.” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST EAGLE FUNDS1,957,1810 00For
Vanguard1,645,0001 00For
Capital Group0764,042 00Against
BlackRock748,9110 00For
ARIEL INVESTMENT TRUST388,1910 00For
Dimensional347,6670 00For
Fidelity309,493189 00For
MFS288,7100 00For
Investment Managers Series Trust III259,1060 00For
Parnassus253,2390 00For
LONGLEAF PARTNERS FUNDS TRUST185,8680 00For
Charles Schwab182,8110 00For
John Hancock135,1450 00For
Allspring94,4700 00For
PIMCO88,1860 00For
T. Rowe Price80,7490 00For
Putnam80,5520 00For
Transamerica65,6920 00For
TRUST FOR PROFESSIONAL MANAGERS64,9770 00For
Equitable47,1040 00For
RBB Fund Trust46,7620 00For
BOSTON TRUST WALDEN FUNDS038,293 00Against
Jackson National6,01030,645 00Mixed
FRANKLIN VALUE INVESTORS TRUST34,7730 00For
TIAA26,3270 00For

Fund voting reports, all 113 managers: 7,650,712 for, 866,604 against, 2,872 abstained, 14 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 352 asset managers voting on “Advisory vote to approve executive compensation.” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
First Eagle Investment Management, LLC2,360,5530 00For
BlackRock516,896951 00For
EARNEST PARTNERS LLC163,973329,131 00Mixed
MASSACHUSETTS FINANCIAL SERVICES CO /MA/456,5030 00For
Capital Group1450,000 00Against
First Pacific Advisors, LP400,7890 00For
State Street375,8524,804 00For
UBS0342,918 00Against
GEODE CAPITAL MANAGEMENT, LLC340,4650 00For
Capital Research Global Investors0314,042 00Against
Parnassus253,2390 00For
ARIEL INVESTMENTS, LLC244,3430 00For
Mawer Investment Management Ltd.0201,944 00Against
Charles Schwab183,7730 00For
Northern Trust174,203632 00For
DEERFIELD MANAGEMENT COMPANY, L.P.170,6020 00For
GW&K Investment Management, LLC169,5370 00For
THOMPSON SIEGEL & WALMSLEY LLC167,6020 00For
Vanguard142,1960 00For
John Hancock127,6620 00For
T. Rowe Price127,6140 00For
ACADIAN ASSET MANAGEMENT LLC125,9690 00For
MELLON INVESTMENTS Corp56123,732 00Against
Putnam115,2020 00For
Allspring109,3040 00For

Institutional-manager reports, all 352 managers: 8,390,520 for, 2,032,568 against, 11,725 abstained, 297 not voted. Showing the 25 largest; see all in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

97% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 10 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 3 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower8,4730 00For
GreenFi Funds Trust07,489 00Against
NORTHERN LIGHTS FUND TRUST II4000 00For

Fund voting reports, all 3 managers: 8,873 for, 7,489 against.

Institutional-manager reports: 6 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
SOUTHEASTERN ASSET MANAGEMENT INC/TN/217,8910 00For
SECTOR GAMMA AS18,7520 00For
Hosking Partners LLP10,4190 00For
MANGROVE PARTNERS IM, LLC00 2,3810Abstain
APG Asset Management US Inc.1,3230 00For
Colony Family Offices, LLC20 00For

Institutional-manager reports, all 6 managers: 248,387 for, 2,381 abstained.

7. 14A Executive Compensation

No official matchSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 914 for, 7 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 914ABSTAIN: 7
Largest asset managers voting on “14A Executive Compensation” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Claret Asset Management Corp9140 00For
LEAVELL INVESTMENT MANAGEMENT, INC.00 70Abstain

8. An Advisory (Non-Binding) Vote to approve Executive Compensation

No official matchSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FORNOT VOTED
Details: votes by 2 asset managers

The 2 asset managers below reported 83,732 for, 15,173 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 83,732NOT VOTED: 15,173
Largest asset managers voting on “An Advisory (Non-Binding) Vote to approve Executive Compensation” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
QVIDTVM Management LLC83,7320 00For
National Philanthropic Trust00 00Not Voted

9. To Approve, By An Advisory Vote, The Compensation Of The Company's Named Executives

No official matchSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 4 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 4
Largest asset managers voting on “To Approve, By An Advisory Vote, The Compensation Of The Company's Named Executives” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Modern Wealth Management, LLC20 00For
Tandem Financial, LLC20 00For

10. Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.

No official matchAUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 114 asset managers

The 114 asset managers below reported 8,516,716 for, 608 against, 2,872 abstained, 14 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,516,716AGAINST: 608ABSTAIN: 2,872NOT VOTED: 14
Largest asset managers voting on “Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST EAGLE FUNDS1,957,1810 00For
Vanguard1,645,0010 00For
Capital Group764,0420 00For
BlackRock748,9110 00For
ARIEL INVESTMENT TRUST388,1910 00For
Dimensional347,6670 00For
Fidelity309,6820 00For
MFS288,7100 00For
Investment Managers Series Trust III259,1060 00For
Parnassus253,2390 00For
LONGLEAF PARTNERS FUNDS TRUST185,8680 00For
Charles Schwab182,8110 00For
John Hancock135,1450 00For
Allspring94,4700 00For
PIMCO88,1860 00For
T. Rowe Price80,7490 00For
Putnam80,5520 00For
Transamerica65,6920 00For
TRUST FOR PROFESSIONAL MANAGERS64,9770 00For
Equitable47,1040 00For
RBB Fund Trust46,7620 00For
BOSTON TRUST WALDEN FUNDS38,2930 00For
Jackson National36,6550 00For
FRANKLIN VALUE INVESTORS TRUST34,7730 00For
TIAA26,3270 00For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

11. Ratify KPMG LLP as Auditors

No official matchSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 16,362 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,362
Largest asset managers voting on “Ratify KPMG LLP as Auditors” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower8,4730 00For
GreenFi Funds Trust7,4890 00For
NORTHERN LIGHTS FUND TRUST II4000 00For
Dixon Mitchell Investment Counsel Inc.00 00--

12. Stockholder proposal regarding dual class capital structure.

No official matchSHAREHOLDER RIGHTS AND DEFENSES

Combines 2 wordings of this item as funds reported it.

92% of fund votes cast · no official result

FOR
Details: votes by 113 asset managers

The 113 asset managers below reported 7,818,748 for, 698,477 against, 2,872 abstained, 14 not voted. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 7,818,748AGAINST: 698,477ABSTAIN: 2,872NOT VOTED: 14
Largest asset managers voting on “Stockholder proposal regarding dual class capital structure.” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
FIRST EAGLE FUNDS1,957,1810 00For
Vanguard1,627,41617,586 00For
Capital Group764,0420 00For
BlackRock748,9110 00For
ARIEL INVESTMENT TRUST0388,191 00Against
Dimensional347,6670 00For
Fidelity309,6820 00For
MFS288,7100 00For
Investment Managers Series Trust III0259,106 00Against
Parnassus253,2390 00For
LONGLEAF PARTNERS FUNDS TRUST185,8680 00For
Charles Schwab182,72289 00For
John Hancock135,1450 00For
Allspring94,4700 00For
PIMCO88,1860 00For
T. Rowe Price80,7490 00For
Putnam80,5520 00For
Transamerica65,6920 00For
TRUST FOR PROFESSIONAL MANAGERS64,9770 00For
Equitable27,10420,000 00Mixed
RBB Fund Trust46,7620 00For
BOSTON TRUST WALDEN FUNDS38,2930 00For
Jackson National34,2002,455 00Mixed
FRANKLIN VALUE INVESTORS TRUST34,7730 00For
TIAA26,3270 00For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

13. Approve Recapitalization Plan for all Stock to Have One-vote per Share

No official matchSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 16,362 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,362
Largest asset managers voting on “Approve Recapitalization Plan for all Stock to Have One-vote per Share” at Bio-Rad Laboratories, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower8,4730 00For
GreenFi Funds Trust7,4890 00For
NORTHERN LIGHTS FUND TRUST II4000 00For
Dixon Mitchell Investment Counsel Inc.00 00--

Largest Bio-Rad Laboratories, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 26,958,000 shares outstanding at the time of that meeting.

Fund voting reports: top Bio-Rad Laboratories, Inc. shareholders by shares voted on “Advisory vote to approve executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1FIRST EAGLE FUNDS 7.26%
2Vanguard 6.10%
3Capital Group 2.83%
4BlackRock 2.78%
5ARIEL INVESTMENT TRUST 1.44%
6Dimensional 1.29%
7Fidelity 1.15%
8MFS 1.07%
9Investment Managers Series Trust III 0.96%
10Parnassus 0.94%
Institutional-manager reports: top Bio-Rad Laboratories, Inc. shareholders by shares voted on “Advisory vote to approve executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1First Eagle Investment Management, LLC 8.76%
2BlackRock 1.92%
3EARNEST PARTNERS LLC 1.83%
4MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.69%
5Capital Group 1.67%
6First Pacific Advisors, LP 1.49%
7State Street 1.41%
8UBS 1.27%
9GEODE CAPITAL MANAGEMENT, LLC 1.26%
10Capital Research Global Investors 1.16%

Reported Bio-Rad Laboratories, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Bio-Rad Laboratories, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 6.58% 13F
BlackRock 6.23% 13F
Dimensional Fund Advisors 4.04% 13F
State Street 2.08% 13F
Geode Capital 1.35% 13F
Northern Trust 0.81% 13F
Charles Schwab 0.73% 13F
Morgan Stanley 0.69% 13F
Franklin Templeton 0.63% 13F
Citadel Advisors 0.56% 13F

Percentages above are of 26,958,000 shares outstanding, as reported by Bio-Rad Laboratories, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Bio-Rad Laboratories, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Bio-Rad Laboratories, Inc.'s shareholder meeting held April 21, 2026, in the 2025-2026 proxy season, 451 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,954 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Bio-Rad Laboratories, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Advisory vote to approve executive compensation. — the reporting funds and managers cast 85% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Bio-Rad Laboratories, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.